Cameroon vs South Korea: Previously treated cases tested for RR-/MDR-TB
Cameroon
100.0%
in 2024
South Korea
100.0%
in 2024
Cameroon rank
1st
South Korea rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Cameroon
- South Korea
How they compare
Cameroon currently reports 100.0% against 100.0% in South Korea, a difference of 0.0%.
The two have swapped places 4 times across 12 shared years of data; in 2013 it was South Korea ahead.
Cameroon ranks 1st and South Korea ranks 1st of 180 countries.
Cameroon has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cameroon | South Korea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 66.9% | 61.6% | 5.3% | Cameroon |
| 2020s | 97.2% | 92.0% | 5.2% | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Cameroon or South Korea?
- Cameroon, at 100.0% against 100.0% in South Korea as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Cameroon and South Korea?
- 0.0%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and South Korea?
- 12 years are reported by both, from 2013 to 2024.
- How do Cameroon and South Korea rank globally for previously treated cases tested for rr-/mdr-tb?
- Cameroon ranks 1st and South Korea ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.